Objectives: Acute renal replacement therapy in patients with sepsis has increased dramatically with substantial costs. However, the extent of variability in use across hospitals-and whether greater use is associated with better outcomes-is unknown. Design: Retrospective cohort study. Setting: Nationwide Inpatient Sample in 2011.
M ultiple studies, including randomized trials, have examined the timing of renal replacement therapy (RRT) among critically ill patients, with mixed results. Some have demonstrated a mortality benefit to early initiation of RRT (1-3), whereas others have suggested no difference when RRT initiation is delayed (4, 5) . This conflicting evidence makes the dual decisions of whether and when to initiate RRT for patients with sepsis challenging for clinicians and may lead to substantial variation in practices surrounding the initiation of RRT for sepsis.
The use of RRT during acute hospitalizations has increased substantially over the past 2 decades (6) (7) (8) , particularly among patients with sepsis (6, 7, (9) (10) (11) (12) . Although the optimal strategy for RRT initiation remains uncertain, patterns of RRT use may provide a glimpse into real-world care provided to patients with sepsis. Early RRT delivery may reduce mortality in the severely ill or could result in unnecessary treatment with increased costs without mortality benefit (13, 14) .
We sought to investigate associations between hospital rates of RRT for sepsis and patient outcomes. Because of the insufficient evidence available to guide clinicians, we hypothesized that there would be substantial variation in RRT use for patients with sepsis. We believed that this variation would result in higher costs for some without differences in mortality.
METHODS
We performed a retrospective cohort study using the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample (NIS) (15). The NIS is the largest publicly available all-payer inpatient healthcare database in the United States, including data from 44 states and the District of Columbia. NIS data from 2011 contain all hospitalizations of a 20% stratified sample of U.S. hospitals. Data from 2011 were used because beginning in 2012, the NIS changed its sampling strategy. Rather than identifying all discharges from 20% of hospitals, it identified 20% of discharges from all hospitals (15).
We included patients 18 years old and older hospitalized with sepsis and acute kidney injury (AKI) in 2011. Patients with sepsis were defined by having International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) diagnosis codes for infection and acute organ dysfunction (eTable 1, Supplemental Digital Content 1, http://links.lww. com/CCM/D80) (16) . This strategy to identify sepsis from administrative data has a specificity of 96.3% and a positive predictive value of 70.7% (17) . AKI was defined by ICD-9-CM diagnosis code (584.X) (6) , and RRT use was identified by ICD-9-CM procedure code (39.95) (6) . The combination of ICD-9-CM codes for AKI and RRT has been validated against chart review and has a positive predictive value of 95.0% and a negative predictive value of 90.0% (18, 19) . We excluded patients admitted to hospitals without RRT capabilities (defined by < five patients receiving RRT in 2011), patients transferred from another hospital (as they may have been initiated on RRT at another hospital), patients with a history of end-stage renal disease (ICD-9-CM diagnosis code 585.6 or procedure codes 39.95 or 54.98 and the absence of ICD-9-CM code for AKI) (20) , or patients who died within 24 hours of hospital admission because they may not have had enough time to be initiated on RRT.
The primary exposure variable was the proportion of patients receiving RRT out of all hospitalized patients with sepsis and AKI. The primary outcome was hospital-level riskadjusted mortality rate (number of in-hospital deaths per 100 patients with sepsis and AKI). Mortality was defined as inhospital death from any cause. We examined the association between hospital RRT rate and patient-level outcomes, such as in-hospital mortality and hospital costs. Hospital costs were calculated by the patient's total hospital charges multiplied by the 2011 hospital-specific cost-to-charge ratio (21) .
We identified the total number and the proportion of patients with sepsis and AKI, who received RRT. Hospitals were ranked and assigned to quintiles based upon the distribution of RRT rates for sepsis and AKI. We also identified the total number and the proportion among all hospitalized patients, who received RRT, at each hospital.
Statistical Analysis
For each hospital, we estimated hospital-specific RRT and mortality rates using hierarchical logistic regression for risk and reliability adjustment (22) . This approach accounts for baseline differences between patients and hospitals and controls for the lower precision of RRT rates for hospitals with few patients (23) . Hospitals using RRT frequently will have estimates approximating their actual rates, whereas hospitals using less RRT will have their rates weighted toward the mean RRT rate for the sample of hospitals (22, 23) .
Risk adjustment was performed to control for any baseline differences between patients and included covariates such as age, sex, race, primary insurance, residential location as stratified by the National Center for Health Statistics Urban/Rural Classification Scheme (24) , preexisting comorbidities according to Elixhauser et al (25) , and severity of illness. Severity of illness was captured using secondary ICD-9-CM diagnosis and procedural codes for acute organ dysfunction (16) , mechanical ventilation (26) , respiratory failure, shock, cardiac or respiratory arrest, and cardiopulmonary resuscitation.
Hospital-level variables were obtained from the American Hospital Association Annual Survey of Hospitals and included in the NIS. Hospital-level risk adjustment included hospital type (not for profit, for profit, government), hospital size (based on hospital beds and specific to the hospital's location and teaching status) (27) , teaching status (defined by whether the hospital has a ratio of 0.25 or higher of full-time equivalent interns and residents to hospital beds) (27) , annual volume of sepsis cases, annual volume of AKI, urbanicity (urban/rural), U.S. region (Northeast, Midwest, South, West), and hospital nursing ratio (number of registered nurse full-time equivalents per 1,000 patient days) (27) .
We compared patient and hospital characteristics across hospitals by quintiles of RRT rates using chi-square tests. To evaluate whether hospital-level RRT rates for patients with sepsis and AKI were associated with hospital-level mortality rates, we performed Spearman's rank correlations. We also used Spearman's rank correlations to assess the association between a hospital's RRT rate for AKI and sepsis and its RRT rate for all hospitalized patients. To examine the association of hospital-level RRT rates with patient-level outcomes, we used generalized estimating equations with robust standard errors with clustering at the hospital level and a logit (mortality) or identity (costs) link. 
Sensitivity Analyses
We performed two sensitivity analyses to evaluate the robustness of our findings. First, we theorized that patients most likely to benefit from RRT would be the most severely ill subgroup of patients. To evaluate whether increased hospital use of RRT might benefit this population of patients, we performed a sensitivity analysis including only severely ill patients with sepsis and AKI. These patients were defined by ICD-9-CM codes for mechanical ventilation, cardiopulmonary resuscitation, shock, or cardiopulmonary arrest (28) . We then evaluated associations between hospital RRT rate and patient-level mortality using generalized estimating equations with robust standard errors with clustering at the hospital level and a logit link function.
Second, we used the 2014 New York state database to assess whether patterns of RRT use for sepsis had changed since 2011. We identified all patients with sepsis and AKI and then calculated risk-and reliability-adjusted RRT rates for all New York hospitals. We then used Spearman's rank correlations to assess the association between a hospital's RRT rate for sepsis and AKI and its overall RRT rate.
Data management and analysis was performed using SAS 9.3 (Cary, NC) and Stata 14.1 (College Station, TX). All tests were two-sided with a p value of less than 0.05 considered significant. The Institutional Review Board for the University of Michigan approved the study and provided a waiver of consent (HUM00053488).
RESULTS
We identified 440 hospitals treating 293,899 patients with sepsis and AKI, of which 18,885 patients (6.4%) received RRT (eFig. 1, Supplemental Digital Content 1, http://links.lww.com/ CCM/D80). The average age of patients with sepsis and AKI was 70.5 (sd, 15.7). Most patients were women (50.8%), white (62.1%), and had Medicare as their primary insurer (70.7%). Crude hospital mortality was 9.9% among all patients with sepsis and AKI and was 22.6% among patients with sepsis and AKI receiving RRT.
The median hospital case-volume for RRT among patients with sepsis and AKI in 2011 was 30 (interquartile range [IQR], 13-60). Hospitals that performed more RRT overall tended to perform RRT at a higher rate for patients with sepsis and AKI (r = 0.59; p < 0.001). After risk and reliability adjustment, the median RRT rate for patients with sepsis and AKI was 3.6% (range, 1.7-13.4%; IQR, 2.9-4.5%) (Fig. 1) . Hospital quintiles of RRT rates for sepsis and AKI were 1.7-2.8%, 2.9-3.3%, 3.4-3.8%, 3.9-4.7%, and 4.8-13.4%.
There were no substantial differences in characteristics of hospitals in the highest quintile of RRT use and all other hospitals ( Table 1 ). There were several clinically meaningful differences between patients in hospitals with the highest RRT use and patients admitted to all other hospitals. For example, patients in high-RRT use hospitals were more likely to be older, have a race/ethnicity other than white, live rurally, have lower median household income, and were more likely to have comorbidities such as heart failure or chronic pulmonary disease ( Table 2) .
There was no association between hospital-level RRT rate for sepsis and AKI and hospital risk-adjusted mortality rate (r = 0.07; p = 0.15). A hospital's RRT rate for sepsis and AKI was not associated with patient-level mortality after adjusting for patient and hospital characteristics (odds ratio [OR] for mortality per 1% increase in RRT rate: 1.03; 95% CI, 0.99-1.07; p = 0.10). However, patients with sepsis and AKI admitted to hospitals that used RRT more frequently had higher hospital costs (absolute cost increase per 1% increase in RRT rate: $1,316; 95% CI, $157-$2,475; p = 0.03). Our sensitivity analyses were consistent with our primary results. There was no significant association between hospitallevel RRT rate and patient-level mortality in the subgroup of 74,033 severely ill patients with sepsis and AKI (OR for mortality per 1% increase in RRT rate: 1.02; 95% CI, 0.99-1.04; p = 0.20). Using 2014 New York state data, we identified 101,262 patients with sepsis and AKI in 122 hospitals. Hospital RRT rates ranged from 1.4% Figure 1 . Renal replacement therapy (RRT) rates by hospital. Each circle represents the risk-and reliabilityadjusted rate of RRT use among patients with sepsis and acute kidney injury at each hospital.
Critical Care Medicine www.ccmjournal.org e161 to 14.6% (median, 5.7%; IQR, 4.2-7.2) (eFig. 2, Supplemental Digital Content 1, http://links.lww.com/CCM/D80). We found no association between hospital-level RRT rate for sepsis and AKI and hospital risk-adjusted mortality rate (r = 0.10; p = 0.28). Approximately, 33.4% (n = 2,086) of patients with sepsis and AKI who received RRT were admitted to the general ward.
DISCUSSION
We identified wide variation across hospitals in the use of RRT for patients with sepsis, independent of severity of illness. Some hospitals used RRT for one of every seven patients with sepsis, whereas other hospitals used RRT for one of every 60 similar patients. Given the variation in RRT use between hospitals and the prevalence of sepsis in the United States, this difference may affect approximately 170,000 Americans each year (16, 29) . Our study used the NIS, an administrative database, to evaluate variation between U.S. hospitals in RRT rates for patients with sepsis. For this analysis, the NIS dataset has several strengths. It provides a national perspective of hospital billing and practice, is commonly used for clinical research with methods validated against chart review, and includes all hospitalized patients, regardless of insurance coverage. However, the NIS also has limitations that must be acknowledged. First, administrative data may imperfectly identify patients. However, we used definitions of sepsis (17) , AKI (18) , and RRT (19) that were previously validated against chart review. Second, the use of administrative data may inadequately account for differences between patients and hospitals. The NIS lacks clinical variables to adjust for many factors important to the decision to start RRT, such as severity of illness scores, laboratory values, or urine output. To account for these limitations, we performed risk adjustment using all available data from the NIS, though residual confounding cannot be excluded. Third, the NIS database is unable to differentiate between intermittent or continuous RRT, how many RRT treatments a patient received, or what type of provider initiated RRT. Fourth, the NIS is unable to establish whether patients were treated in an ICU or general ward. However, our sensitivity analysis using New York state data demonstrated one third of sepsis patients receiving RRT were treated in the general ward. Finally, the NIS database maintains a unique identifier for each hospitalization but not for each patient. Thus, readmissions and postdischarge outcomes are not captured. For instance, the NIS measures only in-hospital mortality. However, hospital discharge practices may bias in-hospital mortality as an outcome compared to 30-day mortality (30) . To account for the limitations of the NIS, we have followed published, best-practice guidelines for the use of NIS and other administrative databases (31) (32) (33) .
RRT is undoubtedly beneficial for patients with select lifethreatening electrolyte abnormalities, who require emergent RRT. However, among patients with sepsis, without these clear indications, there is no consensus to guide clinicians when deciding who should receive RRT and when to initiate (34) . This decision is complex, particularly given the current state of equipoise. Two recent randomized trials demonstrated mixed results between early and late initiation of RRT among critically ill patients, though they used slightly different populations (1, 5) . Observational studies have also failed to tip the scales in either direction (2, 9, (35) (36) (37) (38) .
This conflict is reflected in the variation in RRT rates noted in this study. This analysis is unable to identify the underlying mechanisms driving RRT use, an area in which additional research is needed. However, there are a number of potential causes for this variation, ranging from hospital to clinician to patient factors. Hospitals may have differing capabilities to provide RRT for sepsis, such as dedicated equipment or access to RRT-trained specialists. Hospitals with more expertise in RRT may be more likely to initiate RRT on septic patients without clear-cut indications. For example, in another study, hospitals that used noninvasive ventilation frequently were more likely to provide noninvasive ventilation to patients outside of evidencebased indications (39) . Similarly, we found hospitals that used RRT more for all causes were more likely to initiate RRT for sepsis, for better or worse. We also found evidence of regional variation in care provided for patients with sepsis. Southern hospitals were more likely to use RRT than hospitals in other regions of the United States. The reason for this finding could not be evaluated further but could potentially be related to either southern hospitals caring for sicker patients or RRT initiation practices that differ from other regions of the country. This pattern of geographic variation in healthcare has also been noted in other practices such as ICU utilization for heart failure and tracheostomy placement for mechanically ventilated patients (40, 41) .
This study complements past work that has demonstrated unwarranted variation and overuse in care provided to severely ill patients without obvious improvement in patient outcomes. Life-sustaining therapies in critical care such as tracheostomy, noninvasive mechanical ventilation, and ICU admission are often necessary to prevent death (41) (42) (43) . In some cases, this variation can identify key populations that might benefit from a therapy (28) . However, in most cases, discretionary use of these and other treatments results in substantial variation and excessive costs without obvious benefits to patients (44) (45) (46) . Comparably, our study found that greater hospital use of RRT was not associated with better outcomes but resulted in higher costs, suggesting that improving RRT use for sepsis may be an opportunity to reduce healthcare costs without increasing mortality.
However, the results of this study should not be taken as an indictment of RRT for sepsis. This study cannot identify which patients benefit from RRT use and which do not. Rather, our results should represent a call to action. We highlight the need to improve standards for RRT initiation, as the most appropriate clinical scenarios for using RRT for sepsis remain uncertain. This represents a genuine opportunity to improve patient-centered care and reduce healthcare costs.
Our study has important implications for patients, clinicians, and hospital administrators. When RRT is initiated, patients and families are confronted with a number of complex issues, such as procedures, costs, long-term recovery, and treatment withdrawal (47, 48) . Clinicians and hospital administrators must consider the resource utilization necessary to initiate RRT in the acutely ill patient (49) . This study presents real-world evidence of the need to improve criteria to guide clinicians when deciding whether to initiate RRT for sepsis. Differences in RRT utilization between hospitals, in the absence of meaningful mortality differences, suggest that RRT may be overused, perhaps in patients with weak indications for RRT. Thus, it is imperative to identify patients with sepsis who benefit from RRT and to evaluate at what point during a hospitalization RRT should be initiated.
CONCLUSIONS
Some hospitals use RRT for patients with sepsis four times more than the average hospital. Hospitals with higher RRT rates for sepsis had no difference in mortality with greater associated hospital costs. Improving RRT initiation standards for sepsis may reduce healthcare costs without increasing mortality.
